aTYR PHARMA INC (ATYR) › Net IncomeaTYR PHARMA INC (ATYR) — Net IncomeAnnual figures by fiscal year, from SEC filings.2013: -$20.01M2014: -$24.35M2015: -$47.97M2016: -$57.85M2017: -$48.21M2018: -$34.52M2019: -$16.22M2020: -$16.22M2021: -$33.77M2022: -$45.34M2023: -$50.39M2024: -$64.02M2025: -$74.12M-$74.12M2013Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$74.12M-15.8%2024-$64.02M-27.1%2023-$50.39M-11.1%2022-$45.34M-34.3%2021-$33.77M-108.1%2020-$16.22M+0.0%2019-$16.22M+53.0%2018-$34.52M+28.4%2017-$48.21M+16.7%2016-$57.85M-20.6%2015-$47.97M-97.0%2014-$24.35M-21.7%2013-$20.01M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share